You are here

Data

Only a quarter of Pfizer’s COVID-19 treatment orders will go to developing countries--Oxfam

Just a quarter of Pfizer’s COVID-19 treatment orders will go to developing countries | Oxfam International

Some nations could be paying ten times the price of Paxlovid’s generic equivalent, as WHO chief calls for treatment access to battle acute and long COVID-19

Rich countries have secured almost three times as many courses of a World Health Organisation (WHO)-recommended COVID-19 medicine, Pfizer’s Paxlovid, according to new analysis from Oxfam and the People’s Vaccine Alliance.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Sudy indicates a small riskof seizures among those with long COVID

...the increased risk was among people who were not hospitalized: Of those who dealt with COVID-19 at home, just over 0.7% were later diagnosed with a first-time seizure or epilepsy. That compared with just under 0.5% of people who were sick at home with the flu.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

New COVID-19 subvariants replace BA.5 as most dominant in U.S.

...

The CDC data shows The new BQ.1.1 and BQ.1 together account for roughly 44% of new U.S. COVID-19 infections. The new variants are sublineages of BA.5. It's the first time since July that the BA.5 variant has not been dominant.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Data
howdy folks
Page loaded in 0.787 seconds.